Skip to content

Venture

Blank-300x300

Affiliations

New York University

Technologies

Research Tool

Therapeutic

Indication

Basic Research

Dermatology

Metabolic Disease

Brooklyn Biologics — Our product is a novel formulation of protein and lipids, enabling in vitro/in vivo transfection with DNA/siRNA/miRNA at higher efficiency rates.

Brooklyn Biologics Team:

Carlo Yuvienco, PhD, Co-Founder

Joseph Frezzo

Jin Montclare